TABLE 1 Europe Immune Checkpoint Inhibitors Market, 2017 - 2020, USD Million
TABLE 2 Europe Immune Checkpoint Inhibitors Market, 2021 - 2027, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Immune Checkpoint Inhibitors Market
TABLE 4 Acquisition and Mergers– Immune Checkpoint Inhibitors Market
TABLE 5 Approvals and Trials– Immune Checkpoint Inhibitors Market
TABLE 6 Europe Immune Checkpoint Inhibitors Market by Application, 2017 - 2020, USD Million
TABLE 7 Europe Immune Checkpoint Inhibitors Market by Application, 2021 - 2027, USD Million
TABLE 8 Europe Lung Cancer Market by Country, 2017 - 2020, USD Million
TABLE 9 Europe Lung Cancer Market by Country, 2021 - 2027, USD Million
TABLE 10 Europe Bladder Cancer Market by Country, 2017 - 2020, USD Million
TABLE 11 Europe Bladder Cancer Market by Country, 2021 - 2027, USD Million
TABLE 12 Europe Melanoma Market by Country, 2017 - 2020, USD Million
TABLE 13 Europe Melanoma Market by Country, 2021 - 2027, USD Million
TABLE 14 Europe Hodgkin lymphoma Market by Country, 2017 - 2020, USD Million
TABLE 15 Europe Hodgkin lymphoma Market by Country, 2021 - 2027, USD Million
TABLE 16 Europe Other Application Market by Country, 2017 - 2020, USD Million
TABLE 17 Europe Other Application Market by Country, 2021 - 2027, USD Million
TABLE 18 Europe Immune Checkpoint Inhibitors Market by Type, 2017 - 2020, USD Million
TABLE 19 Europe Immune Checkpoint Inhibitors Market by Type, 2021 - 2027, USD Million
TABLE 20 Europe PD-1 Inhibitor Market by Country, 2017 - 2020, USD Million
TABLE 21 Europe PD-1 Inhibitor Market by Country, 2021 - 2027, USD Million
TABLE 22 Europe PD-L1 Inhibitor Market by Country, 2017 - 2020, USD Million
TABLE 23 Europe PD-L1 Inhibitor Market by Country, 2021 - 2027, USD Million
TABLE 24 Europe CTLA-4 Inhibitor Market by Country, 2017 - 2020, USD Million
TABLE 25 Europe CTLA-4 Inhibitor Market by Country, 2021 - 2027, USD Million
TABLE 26 Europe Immune Checkpoint Inhibitors Market by Country, 2017 - 2020, USD Million
TABLE 27 Europe Immune Checkpoint Inhibitors Market by Country, 2021 - 2027, USD Million
TABLE 28 Germany Immune Checkpoint Inhibitors Market, 2017 - 2020, USD Million
TABLE 29 Germany Immune Checkpoint Inhibitors Market, 2021 - 2027, USD Million
TABLE 30 Germany Immune Checkpoint Inhibitors Market by Application, 2017 - 2020, USD Million
TABLE 31 Germany Immune Checkpoint Inhibitors Market by Application, 2021 - 2027, USD Million
TABLE 32 Germany Immune Checkpoint Inhibitors Market by Type, 2017 - 2020, USD Million
TABLE 33 Germany Immune Checkpoint Inhibitors Market by Type, 2021 - 2027, USD Million
TABLE 34 UK Immune Checkpoint Inhibitors Market, 2017 - 2020, USD Million
TABLE 35 UK Immune Checkpoint Inhibitors Market, 2021 - 2027, USD Million
TABLE 36 UK Immune Checkpoint Inhibitors Market by Application, 2017 - 2020, USD Million
TABLE 37 UK Immune Checkpoint Inhibitors Market by Application, 2021 - 2027, USD Million
TABLE 38 UK Immune Checkpoint Inhibitors Market by Type, 2017 - 2020, USD Million
TABLE 39 UK Immune Checkpoint Inhibitors Market by Type, 2021 - 2027, USD Million
TABLE 40 France Immune Checkpoint Inhibitors Market, 2017 - 2020, USD Million
TABLE 41 France Immune Checkpoint Inhibitors Market, 2021 - 2027, USD Million
TABLE 42 France Immune Checkpoint Inhibitors Market by Application, 2017 - 2020, USD Million
TABLE 43 France Immune Checkpoint Inhibitors Market by Application, 2021 - 2027, USD Million
TABLE 44 France Immune Checkpoint Inhibitors Market by Type, 2017 - 2020, USD Million
TABLE 45 France Immune Checkpoint Inhibitors Market by Type, 2021 - 2027, USD Million
TABLE 46 Russia Immune Checkpoint Inhibitors Market, 2017 - 2020, USD Million
TABLE 47 Russia Immune Checkpoint Inhibitors Market, 2021 - 2027, USD Million
TABLE 48 Russia Immune Checkpoint Inhibitors Market by Application, 2017 - 2020, USD Million
TABLE 49 Russia Immune Checkpoint Inhibitors Market by Application, 2021 - 2027, USD Million
TABLE 50 Russia Immune Checkpoint Inhibitors Market by Type, 2017 - 2020, USD Million
TABLE 51 Russia Immune Checkpoint Inhibitors Market by Type, 2021 - 2027, USD Million
TABLE 52 Spain Immune Checkpoint Inhibitors Market, 2017 - 2020, USD Million
TABLE 53 Spain Immune Checkpoint Inhibitors Market, 2021 - 2027, USD Million
TABLE 54 Spain Immune Checkpoint Inhibitors Market by Application, 2017 - 2020, USD Million
TABLE 55 Spain Immune Checkpoint Inhibitors Market by Application, 2021 - 2027, USD Million
TABLE 56 Spain Immune Checkpoint Inhibitors Market by Type, 2017 - 2020, USD Million
TABLE 57 Spain Immune Checkpoint Inhibitors Market by Type, 2021 - 2027, USD Million
TABLE 58 Italy Immune Checkpoint Inhibitors Market, 2017 - 2020, USD Million
TABLE 59 Italy Immune Checkpoint Inhibitors Market, 2021 - 2027, USD Million
TABLE 60 Italy Immune Checkpoint Inhibitors Market by Application, 2017 - 2020, USD Million
TABLE 61 Italy Immune Checkpoint Inhibitors Market by Application, 2021 - 2027, USD Million
TABLE 62 Italy Immune Checkpoint Inhibitors Market by Type, 2017 - 2020, USD Million
TABLE 63 Italy Immune Checkpoint Inhibitors Market by Type, 2021 - 2027, USD Million
TABLE 64 Rest of Europe Immune Checkpoint Inhibitors Market, 2017 - 2020, USD Million
TABLE 65 Rest of Europe Immune Checkpoint Inhibitors Market, 2021 - 2027, USD Million
TABLE 66 Rest of Europe Immune Checkpoint Inhibitors Market by Application, 2017 - 2020, USD Million
TABLE 67 Rest of Europe Immune Checkpoint Inhibitors Market by Application, 2021 - 2027, USD Million
TABLE 68 Rest of Europe Immune Checkpoint Inhibitors Market by Type, 2017 - 2020, USD Million
TABLE 69 Rest of Europe Immune Checkpoint Inhibitors Market by Type, 2021 - 2027, USD Million
TABLE 70 KEY INFORMATION – ASTRAZENECA PLC
TABLE 71 KEY INFORMATION – BEIGENE LTD.
TABLE 72 KEY INFORMATION – SHANGHAI JUNSHI BIOSCIENCES CO., LTD.
TABLE 73 KEY INFORMATION – BRISTOL MYERS SQUIBB COMPANY
TABLE 74 KEY INFORMATION – GLAXOSMITHKLINE PLC
TABLE 75 KEY INFORMATION – ELI LILLY AND COMPANY
TABLE 76 KEY INFORMATION – MERCK GROUP
TABLE 77 KEY INFORMATION – SANOFI S.A.
TABLE 78 KEY INFORMATION - MERCK & CO., INC.
TABLE 79 KEY INFORMATION – F. HOFFMANN-LA ROCHE LTD.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2017-2021)
FIG 4 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, May – 2021, Dec) Leading Players
FIG 5 Recent strategies and developments: Sanofi s.a.
Unique Offerings 